Merck & Co Inc Stock Price (MRK)

What are Merck & Co stocks?

Although it is now an American multinational, Merck & Co was originally founded in Darmstadt, Germany, in 1668 by Friedrich Jacob Merck. For over 150 years, it operated as a pharmacy before Heinrich Emanuel Merck changed the direction of the business in 1827. Merck Group evolved that year, becoming a manufacturer of drugs including morphine.

In 1891, the company’s US branch of Merck & Co opened in New York. George Merck, Heinrich’s grandson, headed this branch.

As a result of its German connections, the company was nationalised when the US joined World War One. George W Merck bought the company back in 1919 for $3.5 million, but it had to continue as a separate business from its German parent company – and this remains in place today.

Today, the pharmaceutical company is headquartered in Rahway, New Jersey. It now has a global reach, with research and development centres, manufacturing plants and worldwide offices to cater to its international market. Current top-selling products include Keytruda, an antibody used in cancer immunotherapy, and Isentress, a prescription medicine used with other antiretroviral medicines to treat HIV and AIDS.

Where are Merck & Co stocks traded?

MRK stock is traded on the New York Stock Exchange.

Merck & Co stock is also traded as a component on the Dow Jones Industrial Average (DJIA), S&P 100 and S&P 500.

Merck & Co pays a dividend. Between December 2022 and September 2023, MRK stock dividends have been priced at $0.73 per share.

Historical performance of Merck & Co stocks

The company made a public stock offering in 1941. The Merck & Co shares were priced at $28.75 a share and there were 202,372 made available. It was in 1946 that the company listed its shares on the New York Stock Exchange under the ticker MRK.

MRK stock has split nine times. Four of these were two-for-one splits, where for every share of stock owned by a shareholder, they owned two shares post-split. These splits took place in 1949, 1972, 1986 and 1999.

There were also five three-for-one splits, where shareholders owned three shares post-split. The first took place in 1941 before the stock was publicly traded and again in 1951, 1964, 1988 and 1992.

The all-time high for Merck & Co Inc's closing stock price was $116.80 on 8 May 2023. The average stock price in the 52 weeks up to October 2023 was $108.42. The company's market cap up to October 2023 was $253 billion, making it the world's 32nd most valuable company using this criterion.

What influences the price of MRK stocks?

The price of Merck & Co stocks, like those of any publicly traded company, is influenced by a range of factors. Some of these include:

• Economic conditions: Economic factors, such as inflation and GDP growth, can significantly impact the price of MRK shares. Additionally, recessions or periods of uncertainty can lead to market volatility, impacting how share prices perform.
• Global events: Trade tensions or political instability can impact financial markets and, consequently, stock prices.
• Company performance: A company's financial performance is a fundamental driver of stock prices. Strong earnings growth and financial stability can boost investor confidence and drive stock prices higher.

There are industry-specific factors to account for too, such as:

• Drug pipeline: The pharmaceutical industry relies heavily on the success of drugs in the pipeline. Regulatory approvals, clinical trial results and patent expirations can impact stock prices. Positive developments in the pipeline, such as successful clinical trials or FDA (Food and Drug Administration) approvals, tend to drive stock prices higher.
• Healthcare and regulatory environment: Changes in healthcare regulations and government policies can impact on pharmaceutical companies. Regulatory approvals and pricing pressures can affect a company's profitability and stock performance.
• Competition: The pharmaceutical sector is highly lucrative and therefore competitive. The emergence of new drugs and therapies can impact a company's market share and, consequently, its stock price. Merck & Co faces competition from both established pharmaceutical companies and startups.

How can I trade MRK stocks?

One way to trade MRK stock is through financial derivatives. With these, you can enter or exit a trade without owning the underlying asset. Derivatives also allow you to trade in either market direction, speculating on whether the price will increase or decrease.

Contracts for difference (CFDs) enable you to buy or sell a contract based on whether you think the value will increase or decrease. You make a profit or loss relative to the difference in the Merck & Co share price between the opening and closing trades.

Leverage

Leverage allows you to increase your market exposure when trading via derivatives. You open a position with a smaller deposit and therefore get more for less when you profit. However, using leverage can also magnify losses, so be aware of this risk before you enter a trade

How to invest in Merck & Co stock

Investors can purchase MRK stocks. Owning Merck & Co stocks gives investors a share of the company's ownership and potential profit.

Buying stocks can be appealing because it can be a more profitable, longer-term choice than trading via derivatives. By making a purchase, traders can absorb market fluctuations as they come without feeling under pressure to move quickly.

However, buying MRK stock means potential opportunities to profit are limited. This is because the only way to see a return on investment is if the stock's value rises. Should the market enter a prolonged bearish period or drop sharply, investors who own stocks and shares in Merck & Co might be at risk of making a loss.

It's important to note that Merck & Co stocks could be attractive to investors because of the company's dividend policy and share buyback programs. A consistent history of dividend payments and share repurchases can attract income-focused investors.

Advantages of trading Merck & Co stocks

• Trade both ways: Trading MRK stocks through financial derivatives allows you to take advantage of bullish and bearish markets.
• Leverage: When you use leverage, you can open a position with a smaller deposit. This presents an opportunity to potentially maximise your capital. However, losses can also be enhanced should your trade go against your prediction.
• Market exposure: Merck & Co is an established name on the New York Stock Exchange, along with other exchanges, so trading its shares means you'll gain exposure across a major market.

Disadvantages of MRK stocks

• Leverage risk: Leverage used to increase your position can leave you at risk of losses or increased profits.
• Market fluctuations: Market volatility is unpredictable. Even with detailed technical analysis, markets can occasionally move in unexpected ways. Although the MRK stock price today appears to be stable, it could change tomorrow if something unforeseen occurs.
• Restricted portfolio: Trading just one company's stock restricts your portfolio and can make you vulnerable to dramatic changes in MRK price movements.

How to start trading MRK stocks with Tradu

1. Open an account: Open a Tradu account online to begin trading.
2. Form a strategy: Work out your risk tolerance levels, set trading goals and choose your preferred markets.
3. Research: View historical data for MRK stock, compare it with the stock price today per share, and apply technical indicators to maximise your profit-making opportunities.
4. Open your position: Use risk management tools to help you limit losses as you place your trade, then monitor before closing your position.
5. Use trading resources: Our insights may help you discover new trading angles and broaden your opportunities.
6. Diversify your portfolio: Grow your trading portfolio with a range of other markets including forex, crypto,  indices and commodities.